Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
The Annals of Pharmacotherapy|April 1, 1992
Evaluation of two over-the-counter natural thyroid hormone preparations in human volunteersG Csako, D M Corso, J Kestner, et al.Pharmacotherapy|July 25, 2000
Quality of pharmacotherapy consultations provided by drug information centers in the United StatesK A Calis, D W Anderson, D A Auth, et al.Journal of Clinical Psychopharmacology|April 19, 2000
Olanzapine pharmacokinetics in pediatric and adolescent inpatients with childhood-onset schizophreniaD R Grothe, K A Calis, L Jacobsen, et al.American Journal of Ophthalmology|April 1, 1996
Intraocular levels of methotrexate after intravenous administrationM D de Smet, V Stark-Vancs, D R Kohler, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 18, 1998
Standardizing the expression and nomenclature of cancer treatment regimens. American Society of Health-System Pharmacist (ASHP), American Medical Association (AMA), American Nurses Association (ANA)D R Kohler, M J Montello, L Green, et al.Cancer|April 15, 1995
A phase I study of the somatostatin analogue somatuline in patients with metastatic hormone-refractory prostate cancerW D Figg, A Thibault, M R Cooper, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Phase II and dose-escalation with or without granulocyte colony-stimulating factor study of 9-aminocamptothecin in relapsed and refractory lymphomasW H Wilson, R Little, D Pearson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphomaW H Wilson, G Bryant, S Bates, et al.Panminerva Medica|October 8, 2014
A clinical research integration special program (CRISP) for young women with primary ovarian insufficiencyA Falorni, V Minarelli, C M Eads, et al.Cancer|June 15, 1995
Phase I study of phenylacetate administered twice daily to patients with cancerA Thibault, D Samid, M R Cooper, et al.Pageof 4